Group One Trading, L.P. Biovie Inc. Transaction History

Group One Trading, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.53 - $1.89 $5,365 - $19,132	10,123 New	10,123 $5,000
Q3 2023 Nov 09, 2023	BUY	$2.75 - $5.17 $9,116 - $17,138	3,315 Added 17.84%	21,892 $74,000
Q2 2023 Aug 09, 2023	BUY	$4.09 - $8.29 $53,427 - $108,292	13,063 Added 236.91%	18,577 $80,000
Q1 2023 May 12, 2023	BUY	$4.89 - $10.53 $26,963 - $58,062	5,514 New	5,514 $44,000

4.73M

17.2K

27K

Ticker BIVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,165,300
Market Cap $83.6M
Description
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.